Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Georg Nölker , Dieter Horstkotte , Klaus-Jürgen Gutleben Added: 3 years ago
Catheter ablation is an established treatment option for patients with symptomatic atrial fibrillation (AF).1-3 Pulmonary vein (PV) angiography has been the initial imaging tool in AF ablation and is still used by up to 50 % of leading electrophysiologists.3 PV angiography still plays a major role in balloon-based ablation techniques routinely performed without electroanatomical mapping (EAM)… View more
Author(s): Ngai-Yin Chan Added: 3 years ago
Atrial fibrillation (AF) is the most common sustained heart rhythm disorder1 and in a recently conducted community screening programme in Hong Kong the total burden of AF in the population was estimated to be 0.77% in 2016. This is predicted to increase to 1.1% in 2030 due to population ageing, see Figure 1.2 As in other developed countries and regions with ageing populations, AF has become an… View more
Author(s): Mads Brix Kronborg Added: 7 months ago
ESC 2023 — Dr Mads Brix Kronborg (Aarhus University Hospital, DE) joins us to discuss the findings from the DANPACE II Trial (NCT00236158). DANPACE II (The DANPACE Investigator Group) trial aimed to compare patients who were randomised in a 1:1 ratio to either a base rate of 60 beats per minute and rate-adaptive DDD (DDDR-60 Group) or a base rate of 40bpm and non-rate adaptive DDD (DDD-40… View more
Author(s): Georgios Giannopoulos , Spyridon Deftereos Added: 3 years ago
Dear Sir, We read with great interest the meta-analysis by Pearman et al.1 on the comparison between epicardial ablation for atrial fibrillation and the hybrid approach. The authors should be commended on the way they handled the data. The imbalance between the two meta-analytic cohorts – in terms of the type of atrial fibrillation and left atrial diameter – may have worked to the detriment of… View more
Author(s): Ilan Goldenberg Added: 2 years ago
In this interview, Dr Illan Goldenberg (University of Rochester Medical Center, Rochester, NY, US) presents the findings of a study aiming to evaluate the effect of SGLT2is on atrial arrhythmia burden in patients with ICDs. Originally revealed at AHA 2021, the results suggest that treatment with SGLT2 inhibitors was associated with a significant reduction in the risk of total atrial arrhythmic… View more
Author(s): Charles M Pearman , Dhiraj Gupta Added: 3 years ago
Dear Sir, We thank Drs Giannopoulos and Deftereos for showing interest in our work.1 They wonder whether a true difference might exist between hybrid and epicardial ablation alone that may have been masked by our combining the results from retrospective observational studies with those from randomised trials. A fine balance needs to be struck for this type of analysis. On one hand, adopting… View more
Author(s): Hugh Calkins Added: 6 years ago
Interview with Hugh Calkins from the Johns Hopkins Hospital, Baltimore, MD, USA at EHRA 2017 summarizingkey points from theHRS Expert Consensus Statement on Catheter & Surgical Ablation of Atrial Fibrillation Filmed by Radcliffe Cardiology on-site at EHRA 2017 View more
Author(s): Andreas Goette , Hein Heidbuchel Added: 3 years ago
AF is the most common sustained cardiac arrhythmia and poses a significant public health challenge.1 In cases of AF, if sinus rhythm does not spontaneously return, cardioversion may be needed to alleviate symptoms and to improve cardiac performance.2 This may be performed by pharmacological methods, i.e. the administration of antiarrhythmic drugs, which is the preferred strategy in recent-onset… View more